Novo's new insulin pen allows finer-scale adjustments

08/21/2013 | Drug Store News

Novo Nordisk received federal approval for its NovoPen Echo insulin pen, which enables half-unit dosing. The smaller doses allow for more precise adjustments, particularly helpful for treating children with diabetes. The device, the first of its kind in the U.S., also features a memory function that keeps track of dose and time frame between shots.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX